Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00519766 · ClinicalTrials.gov registry record
Examining a New Biomarker of Nicotine Use Among Pregnant Women Who Participated in the New England SCRIPT
A clinical trial, sponsored by Memorial Hospital of Rhode Island.
- Completed
- Registry status
- 252
- Enrollment target
NCT00519766 is a clinical trial that has completed, run by Memorial Hospital of Rhode Island. The registered enrollment target is 252 participants.
The verdict
NCT00519766 has completed, sponsored by Memorial Hospital of Rhode Island.
- COMPLETED
- Registry status
- 252 participants
- Enrollment target
Study Summary
Smoking during pregnancy is the single most preventable cause of illness and death among mothers and infants. Because of the stigma associated with tobacco use during pregnancy, pregnant women are less likely to disclose their smoking status to doctors or study researchers. This study will evaluate the use of a new biomarker of nicotine metabolism to estimate tobacco use in a group of pregnant women who participated in the New England Smoking Cessation and Reduction in Pregnancy Trial (SCRIPT).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 1997-09 |
| Est. Completion | 2002-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00519766
The ClinicalTrials.gov registry entry for NCT00519766 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Hospital of Rhode Island, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00519766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00519766 about?
NCT00519766 is a clinical study titled "Examining a New Biomarker of Nicotine Use Among Pregnant Women Who Participated in the New England SCRIPT". Smoking during pregnancy is the single most preventable cause of illness and death among mothers and infants. Because of the stigma associated with tobacco use during pregnancy, pregnant women are less likely to disclose their smoking status to doctors or study researchers. This study will evaluate ...
What is the current status of trial NCT00519766?
This trial is currently completed. The enrollment target is 252 participants. The study started on 1997-09. Estimated completion is 2002-11.
Who is sponsoring clinical trial NCT00519766?
This trial is sponsored by Memorial Hospital of Rhode Island, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.